These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2208144)

  • 1. Sialomucin and lytic susceptibility of rat mammary tumor ascites cells.
    Moriarty J; Skelly CM; Bharathan S; Moody CE; Sherblom AP
    Cancer Res; 1990 Nov; 50(21):6800-5. PubMed ID: 2208144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tunicamycin on sialomucin and natural killer susceptibility of rat mammary tumor ascites cells.
    Bharathan S; Moriarty J; Moody CE; Sherblom AP
    Cancer Res; 1990 Sep; 50(17):5250-6. PubMed ID: 2386935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface sialomucin and resistance to natural cell-mediated cytotoxicity of rat mammary tumor ascites cells.
    Sherblom AP; Moody CE
    Cancer Res; 1986 Sep; 46(9):4543-6. PubMed ID: 3731108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfation of the tumor cell surface sialomucin of the 13762 rat mammary adenocarcinoma.
    Hull SR; Carraway KL
    J Cell Biochem; 1989 May; 40(1):67-81. PubMed ID: 2745574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target cell membrane modification and susceptibility to lymphokine-activated killer cell-mediated lysis. II. Sodium periodate has a differential effect on the lysis of human and murine tumor cells.
    Midis GP; Gupta VK; Fabian DF; Lefor AT
    J Surg Res; 1994 Feb; 56(2):146-54. PubMed ID: 8121171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
    J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids.
    Kiyohara T; Dennis JW; Boegman RJ; Roder JC
    J Immunol; 1985 Jul; 135(1):659-64. PubMed ID: 3923114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.
    Lobo PI; Spencer CE
    J Clin Invest; 1989 Jan; 83(1):278-87. PubMed ID: 2463268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
    Roozemond RC; van der Geer P; Bonavida B
    J Immunol; 1986 May; 136(10):3921-9. PubMed ID: 3701064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and partial characterization of ascites sialoglycoprotein-2 of the cell surface sialomucin complex of 13762 rat mammary adenocarcinoma cells.
    Hull SR; Sheng Z; Vanderpuye O; David C; Carraway KL
    Biochem J; 1990 Jan; 265(1):121-9. PubMed ID: 2302161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
    Sheil JM; Gallimore PH; Zimmer SG; Sopori ML
    J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of UV light on tumor cell sensitivity to NK and NC cell-mediated lysis.
    Begovic M; Herberman RB; Gorelik E
    Nat Immun; 1993; 12(4-5):250-66. PubMed ID: 8257830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis of the cell surface sialomucin complex of ascites 13762 rat mammary adenocarcinoma cells from a high molecular weight precursor.
    Sheng ZQ; Hull SR; Carraway KL
    J Biol Chem; 1990 May; 265(15):8505-10. PubMed ID: 2111320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of simple sugars on natural killing: evidence against the involvement of a lectin like mechanism in target recognition.
    Vose BM; Harding M; White W; Moore M; Gallagher J
    Clin Exp Immunol; 1983 Mar; 51(3):517-24. PubMed ID: 6682730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.